Actos Lawsuits Move Forward, as Second Pilot Bellwether Trial in Federal Actos Bladder Cancer Litigation is Put on Hold, Bernstein Liebhard LLP Reports

The Firm is representing clients in Actos lawsuits that allege long-term use of the Type 2 diabetes drug caused bladder cancer.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Free Case Review
We are representing a number of clients in Actos lawsuits who allege use of this medication caused their bladder cancer. We are looking forward to more progress in this litigation, especially the start of the first bellwether trial next week.

New Yor, New York (PRWEB) January 26, 2014

Actos lawsuits (http://www.consumerinjurylawyers.com/actos/Actos-Lawsuit.html) alleging long-term use of the Type 2 diabetes drug can cause bladder cancer continue to move forward in the federal multidistrict litigation now underway in U.S. District Court, Western District of Louisiana, Bernstein Liebhard LLP reports. According to an Order issued on January 15, 2014, the Court has continued the litigation’s second pilot bellwether trial until further notice, and has suspended all deadlines previously set in the matter. The Order further directs the litigation’s Special Masters to schedule a telephone conference within the next two weeks to establish a new date for the trial, which was originally scheduled to begin on April 14, 2014. (In re: Actos Product Liability Litigation, MDL No. 2299)

“We are representing a number of clients in Actos lawsuits who allege use of this medication caused their bladder cancer. We are looking forward to more progress in this litigation, especially the start of the first bellwether trial next week,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal evaluations to individuals who were treated with Actos for a year or more, and who allegedly went on to develop bladder cancer due to their use of the drug.

Actos and Bladder Cancer
The federal Actos litigation was established in December 2011, following an alert issued by the U.S. Food & Drug Administration in June of that same year which warned that use of the medication for a year or more could be associated with an increased risk of bladder cancer. According to court documents, nearly 2,700 Actos bladder cancer claims have since been filed in the proceeding, all of which accuse Takeda Pharmaceuticals of concealing the medication’s link to bladder cancer, and failing to provide adequate warnings to doctors and patients. The litigation’s first bellwether trial is scheduled to start on Monday, January 27, 2014.

Court documents indicate that scores of Actos lawsuits involving similar allegations have been filed in state courts around the country, three of which went to trial last year. In April, an Actos bladder cancer plaintiff was awarded more than $6.5 million by a Los Angeles Superior Court Jury in September. However, that verdict was set aside by the judge overseeing the case, and is currently on appeal. (Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court)

In September, a Maryland State Court jury awarded $1.7 million to the family of a man who died of bladder cancer following long-term use of Actos. However, the judge presiding over the lawsuit overturned the verdict because the jury also found that the decedent’s decades-long smoking habit contributed to the development of the disease. (An v. Nieberlein, 24-C12003565, Circuit Court for the City of Baltimore, State of Maryland.)

Most recently, an Actos bladder cancer trial concluded in December, with a Nevada jury finding for the defense. (Alsabagh v. Takeda Pharmaceuticals America Inc., A-12-665708-C, Clark County District Court, Nevada (Las Vegas)

Individuals who developed bladder cancer allegedly due to their use of Actos may be entitled to compensation for their injury-related damages. To learn more about filing an Actos lawsuit, please visit Bernstein Liebhard LLP’s website. For additional information, please call 800-511-5092 today.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com